Skip to main content

Standpoint Asset Management, LLC

13F filer · CIK 0001780423
Reported Jul 23, 2026
Net buyer this quarter
13F portfolio value$477MU.S. long equity reported on 13F
Positions10 new · 0 closed
Net flow last quarter+$1.65MBuys minus sells
Top 10 positions weight8.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Jul 23, 20261 positions
IDEVEndo Pharmaceuticals Solutions Inc.$42.1M8.82%Not reported+4.1%Q4 2022
Q1 2026Reported Apr 16, 20261 positions
IDEVEndo Pharmaceuticals Solutions Inc.$37.9M9.20%Not reported-3.3%Q4 2022
Q4 2025Reported Feb 12, 20261 positions
IDEVEndo Pharmaceuticals Solutions Inc.$38.7M8.85%Not reported-3.4%Q4 2022
Q3 2025Reported Nov 6, 20251 positions
IDEVEndo Pharmaceuticals Solutions Inc.$39M8.81%Not reported-15.5%Q4 2022
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.